The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is
critical for virus infection through the engagement of the human ACE2 protein 1 and is a major …

SARS-CoV-2 Spike protein is critical for virus infection via engagement of ACE2, and amino
acid variation in Spike is increasingly appreciated. Given both vaccines and therapeutics …

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines show
protective efficacy, which is most likely mediated by neutralizing antibodies recognizing the viral …

The coronaviral spike is the dominant viral antigen and the target of neutralizing antibodies.
We show that SARS-CoV-2 spike binds biliverdin and bilirubin, the tetrapyrrole products of …

SARS-CoV-2 infection elicits similar antibody responses in HIV-negative individuals and
people living with HIV that is well controlled by antiretroviral therapy (ART). 1 SARS-CoV-2 …

Memory B cells (MBCs) can provide a recall response able to supplement waning antibodies
(Abs) with an affinity-matured response better able to neutralize variant viruses. We studied …

We assessed a cohort of people living with human immunodeficiency virus (PLWH) (n = 110)
and HIV negative controls (n = 64) after 1, 2 or 3 SARS-CoV-2 vaccine doses. At all …

We read with interest the letter by Roeker et al., on SARS-CoV-2 antibody responses in
twenty-one patients with chronic lymphocytic leukemia (CLL), reporting that 67% generated …

Natural killer (NK) cell subsets with adaptive properties are emerging as regulators of
vaccine-induced T and B cell responses and are specialized towards antibody-dependent …

In the version of this article initially published, the surname of a member of The COVID-19
Genomics UK (COG-UK) Consortium was misspelt as Gramatopoulos. The correct spelling is …